Navigation Links
Long-Term 12-Month Safety Data Presented on ADHD Patch DAYTRANA(TM) (methylphenidate transdermal system)
Date:10/25/2007

in that are not historical facts are forward- looking statements. Such forward-looking statements involve a number of risks and uncertainties and are subject to change at any time. In the event such risks or uncertainties materialize, Shire's results could be materially affected. The risks and uncertainties include, but are not limited to, risks associated with: the inherent uncertainty of pharmaceutical research, product development (including the successful development of JUVISTA(R) (Human TGFb3)) manufacturing and commercialization (including the launch and establishment in the market of VYVANSE); the impact of competitive products, including, but not limited to the impact of those on Shire's Attention Deficit and Hyperactivity Disorder ("ADHD") franchise; patents, including but not limited to, legal challenges relating to Shire's ADHD franchise; government regulation and approval, including but not limited to the expected product approval date of INTUNIV(TM) (guanfacine) extended release (ADHD) and GA-GCB (Gene-Activated Glucocerebrosidane); Shire's ability to secure new products for commercialization and/or development; Shire's ability to benefit from its acquisition of New River Pharmaceuticals Inc.; and other risks and uncertainties detailed from time to time in Shire plc's filings with the Securities and Exchange Commission, particularly Shire plc's Annual Report on Form 10-K for the year ended December 31, 2006.

Daytrana(TM) is a trademark of Shire Pharmaceuticals Ireland Limited.


'/>"/>
SOURCE Shire plc
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Anesiva Announces Phase 2 Data Showing Substantial, Long-Term Pain Reductions with Adlea(TM) (formerly 4975) in Osteoarthritis of the Knee
2. Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival
3. 8-Year Long-term Data Demonstrate Prolonged Overall Survival and Length of Disease Remission with Bexxar
4. Surfaxin (Lucinactant) Long-Term Survival Advantage vs. Comparators Published in Pediatrics
5. Vaxfectin-formulated Measles DNA Vaccine Elicits Long-term Protection and Sterilizing Immunity in Nonhuman Primates
6. Long-Term Extension of Ulcerative Colitis Study Shows Remicade Responders Maintained Improvement Through Two Years of Follow-Up
7. New Long-Term Data Analyses for Bifeprunox Show Favorable Effects Versus Placebo in Stabilized Patients with Schizophrenia
8. Medtronic Updates Long-Term ENDEAVOR I-II Clinical Data Showing Sustained Safety and Significant Reductions in Repeat Procedures
9. Taxus VI Clinical Trial Demonstrates Positive Long-Term Outcomes for Moderate-Release Paclitaxel-Eluting Stent at Four Years
10. UCB Presents Long-Term CImzia Data in Crohns Disease
11. PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007 Digestive Disease Week
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... 14, 2014  Luminex Corporation (Nasdaq: LMNX ... for the fourth quarter of 2013 on Monday, February ... scheduled for release after the close of trading. ... will hold a conference call to discuss the operating ... twelve months ended December 31, 2013 on February 3, ...
(Date:1/14/2014)... HARRISBURG, Pa. , Jan. 14, 2014 Dynamic ... LLC ("GMH"), announced today that it acquired Progressive Home Medical ... on January 7, 2014. The terms of the acquisition were ... durable medical equipment ("DME") company providing a wide range of ... Pennsylvania and Pittsburgh ...
(Date:1/14/2014)... Minn. , Jan. 14, 2014   NuAire , ... research, have come to agreement with Hitachi Koki ... the Hitachi brand of centrifuges in North America ... throughout the United States and ... product benefits and features, options and accessories, training, pricing, as ...
Breaking Medicine Technology:Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 3NuAire announces sales and service of Hitachi Koki centrifuges in North America 2
... Group, a free standing in-home health company serving ... will be partnering with Cardiocom® to expand its ... to patients with chronic conditions.  Cardiocom, Experts in ... clinical service provider of award-winning telehealth solutions. ...
... Tengion, Inc. (Nasdaq: TNGN ) today announced that ... Pharmaceuticals (Nasdaq: ENDP ) as Senior Vice President, ... Directors. Tengion also announced today that Brenda ... from the Tengion Board of Directors after five years of ...
Cached Medicine Technology:THA Group Partners with Cardiocom Telehealth 2Tengion Appoints Diane Jorkasky, M.D., to its Board of Directors 2
(Date:4/14/2014)... orphaned by HIV/AIDS in South Africa may provide insight ... behavior issues in other areas of the world, which ... that could lead to successful interventions. , A ... United Nations mentions that due to the HIV/AIDS pandemic, ... African, children are at an increased risk for mental ...
(Date:4/14/2014)... A new study shows that moderate to severe ... risk of stroke, cancer and death. , Results of ... to severe obstructive sleep apnea were four times more ... times more likely to have a stroke (HR = ... (HR = 3.4), and 2.5 times more likely to ...
(Date:4/14/2014)... Dallas study involving serious youth offenders, the answer to one ... seven years: "How long do you think you,ll live?", According ... offending over time., Author Dr. Alex Piquero said the study ... of them offend at very high rates and commit more ... much later in life offend much less., "In a lot ...
(Date:4/14/2014)... with symptoms increasing dramatically during some of the most important ... has found. , Depressive symptoms increased on average by 68 ... young men, who were around 25 years old when they ... their children. The results of the study were published April ... is the first to identify when young fathers are at ...
(Date:4/14/2014)... Lower weight babies and babies who aren,t breastfed ... risk of developing chronic inflammation and related health ... study. , "There were good reasons to hypothesize ... inflammation in adulthood," says Thomas McDade (Northwestern University), ... in the Child & Brain Development program. "It ...
Breaking Medicine News(10 mins):Health News:Researchers identify children with emotional behavior difficulties 2Health News:Researchers identify children with emotional behavior difficulties 3Health News:Study links severe sleep apnea to increased risk of stroke, cancer and death 2Health News:UT Dallas study: Youth who fail to envision future commit more crimes 2Health News:Young dads at high risk of depression, too 2Health News:Low birth weight, less breastfeeding create later health risks 2
... cancer is one of the most common cancers occurring ... of Eloxatin drug with other chemotherapeutic cancer drug for ... and reduced recurrence in these patients. This study which ... of Eloxatin with chemotherapeutic drugs more effective than control ...
... team of researchers, led by Dr. Martine Roussel of the ... of medulloblastoma, the most common malignant brain tumor found in ... are formed by cells which are not yet mature or ... are usually formed in the second part of the brain ...
... the first time been able to turn the embryonic stem ... give rise to organs such as pancreas, liver and lungs. // ... cells to repair diseased or damaged organs. The embryonic stem cells ... all the different cell types found in the human body. The ...
... discovered the 'DCDC2' gene associated with dyslexia. Dyslexia causes ... world. // , ,The gene called 'DCDC2' gene ... researchers. The researchers found that a genetic alteration in ... and this genetic alteration is transmitted within families. , ...
... leads to inflammation of the liver is common among intravenous ... suffering from // the disease in the United States. ... the effects of drug abuse, specifically opiates, on progression of ... treatment of both HCV infection and drug abuse. It has ...
... A recent study done by Household Food Security in the ... go hungry, including nearly 14 million children. This accounts for ... ,'This is an unexpected and even stunning outcome,' noted center ... domestic hunger. 'This chronic level of hunger so long after ...
Cached Medicine News:Health News:Stem cells Can Generate Organs In Labs 2Health News:Chromosome 6 has the Dyslexia Gene 2Health News:Morphine Withdrawal Complicates Hepatitis C Infection in Drug Abusers 2
Tennant angled tying forceps with extra delicate smooth jaws, 6 mm tying platform, For 9-0 to 11-0 sutures. Overall length 108 mm....
Catalano curved tying forcep has 6 mm V-grove tying platform. Overall length 100 mm....
Kelman - McPherson angled tying forceps is long with tying platform 10 mm, serrated handle and polished finish....
Suture tying forceps (S&T) is straight, 13.5 cm long, flat handle, 9 mm wide, tip diameter 0.3 mm with tying platform....
Medicine Products: